Diabetes and Heart Disease

Similar documents
Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

Diabetes Mellitus: A Cardiovascular Disease

Established Risk Factors for Coronary Heart Disease (CHD)

Session 21: Heart Health

Chapter 18. Diet and Health

Cardiovascular Complications of Diabetes

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group

Health Score SM Member Guide

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Disclosures. Outline. Metabolic Syndrome and Diabetes: Evaluating CVD Risk and Strategies for CVD Risk Reduction

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t?

Also, some risk factors, such as smoking and diabetes, put you at greater risk for CHD and heart attack than others.

NEW GUIDELINES FOR CHOLESTEROL

Rick Fox M.A Health and Wellness Specialist

Clinical Recommendations: Patients with Periodontitis

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN

Long-Term Complications of Diabetes Mellitus Macrovascular Complication

Clinical Care Performance. Financial Year 2012 to 2018

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century November 2, 2016

Lipoprotein Particle Profile

Controversies in Preventative Cardiology

Cardiovascular Disease Risk Factors:

Macrovascular Disease in Diabetes

Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009

7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313)

Living a Heart Healthy Life. Eleanor Stewart, MSN, RN, AGACNP-BC

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida

Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018

Heart Disease and Diabetes Teaching Module

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

Diabetic Dyslipidemia

1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver)

No relevant financial relationships

The Metabolic Syndrome: Is It A Valid Concept? YES

Lipid Management 2013 Statin Benefit Groups

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG

Welcome and Introduction

!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

What is Diabetes Mellitus?

Cardiovascular Disease

Risk Factors for Heart Disease

10/8/2015. MN Nursing Conference October 7th, 2015 Michael Miedema, MD MPH. None

The Diabetes Link to Heart Disease

ASSeSSing the risk of fatal cardiovascular disease

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

The Heart of Women s Health

STAYING HEART HEALTHY PAVAN PATEL, MD CONSULTANT CARDIOLOGIST FLORIDA HEART GROUP

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Young high risk patients the role of statins Dr. Mohamed Jeilan

KEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

When Statins Aren t Enough: Appropriate Therapies for High-Risk Patients with Diabetes

Metabolic Syndrome: What s so big about BIG?

Nutrition and Heart Disease. by Rachel Kay, MS, RDN, CD Clinical Nutrition Specialist at Swedish Medical Center

Test5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight

HEART HEALTH AND HEALTHY EATING HABITS

Men & Women: Differences in Heart Disease

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,

2013 Hypertension Measure Group Patient Visit Form

POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) Term-End Examination June, 2015

MOLINA HEALTHCARE OF CALIFORNIA

CHOLESTEROL CONTENT CREATED BY. Learn more at

Low carbohydrate diets- do they have a place?

Treatment to reduce cardiovascular risk: multifactorial management

Insert logo. Linda Main, Dietetic Adviser

Diabetes Education Teaching Guide! Heart Disease & Diabetes!

Women and Heart Disease

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

How to Prevent Heart Disease

New Guidelines in Dyslipidemia Management

Case Presentation. Moderator: Sharon Liu, DO Associate Internal Medicine Chief Austin Regional Clinic Austin, Texas

How would you manage Ms. Gold

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up

SIGN 149 Risk estimation and the prevention of cardiovascular disease. Quick Reference Guide July Evidence

Dyslipedemia New Guidelines

Metabolic Syndrome.

Lipids. PBHL 211 Darine Hachem, MS, LD

Metabolic Syndrome and Chronic Kidney Disease

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century October 4, 2010

Cardiovascular System and Health. Chapter 15

Metabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Update in Cardiology Pharmacologic Management of Cardiovascular Risk. Christopher C. Roe, MSN, ACNP

Diabetes and Concomitant Cardiovascular Disease: Guideline Recommendations and Future Directions

Clinical Practice Guidelines for Diabetes Management

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk

Common Diabetes-related Terms

Prevention of Heart Disease: The New Guidelines

Transcription:

Diabetes and Heart Disease Sarah Alexander, MD Assistant Professor of Medicine Division of Cardiology Rush University Medical Center 2/8/2017 Rush is a not-for-profit health care, education and research enterprise comprising Rush University Medical Center, Rush University, Rush Oak Park Hospital and Rush Health.

What s the problem?? Diabetes mellitus (DM) affects 1 in 10 US adults 90-95% of cases are type 2 DM DM is becoming an increasing problem in children Ø Prevalence has increased by 30.5% between 2001-2009 Women with DM live an average of 8.2 years less than those without DM DM is considered a coronary heart disease risk equivalent Heart disease is the #1 cause of death in the US Mozaffarian D, Benjamin EJ, Go AS, et al; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommitte. Heart Disease and Stroke Statistics 2016 Update a report from the American Heart Association. Circulation. 2016;133:000-000 2

East-West Study Events*/100 person-years 50 40 30 20 10 0 45 Prior CHD No prior CHD DM No DM Patients with DM and no prior history of heart attack had 19 a similar rate 20 of having a heart attack as patients who don t have DM but with a prior history of heart attack. 3.5 Slide adapted from acc.org *Fatal or non- fatal MI CHD=Coronary heart disease, DM=Diabetes mellitus, MI=Myocardial infarcxon Source: Haffner SM et al. NEJM 1998;339:229 234

Complica7ons of Diabetes MICROvascular ReXnopathy (most common) Neuropathy (Xngling, burning, numbness) Nephropathy (kidney disease) 4

Complica7ons of Diabetes MACROvascular Coronary heart disease (heart a\ack, narrowing of the heart arteries) Peripheral arterial disease Stroke 5

Lifestyle risk factors Physical inacxvity Diet Obesity Smoking 6

Metabolic risk factors High blood pressure (Hypertension, HTN) High cholesterol (dyslipidemia, hyperlipidemia) High blood sugar 7

Metabolic syndrome Need at least 3 of the following risk factors: Waist circumference >35 inches in females (>40 inches in males) HDL <50 mg/dl in females, <40 mg/dl in males Triglycerides 150 mg/dl Fasting glucose 110 mg/dl Blood pressure 130/ 85 mmhg Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 2001;285:2486-2497 8

Mechanisms Chronic inflammaxon and injury AcXvates the immune system which leads to development of fa\y plaque This can occur in the heart arteries (coronary arteries) or the arteries in the legs (peripheral arteries) Platelets are more sxcky which can promote formaxon of blood clots 9

Inflammation IL-6 CRP SAA Infection Defense mechanisms Pathogen burden Hyperglycemia AGE Oxidative stress Subclinical Atherosclerosis Insulin Resistance HTN Endothelial dysfunction Dyslipidemia LDL TG HDL Thrombosis PAI-1 TF tpa Subclinical: not readily detected or easily seen; you do not manifest signs/symptoms of the disease yet Disease Progression Atherosclerotic Clinical Events AGE=Advanced glycation end products, CRP=C-reactive protein, CHD=Coronary heart disease HDL=High-density lipoprotein, HTN=Hypertension, IL-6=Interleukin-6, LDL=Low-density lipoprotein, PAI-1=Plasminogen activator inhibitor-1, SAA=Serum amyloid A protein, TF=Tissue factor, TG=Triglycerides, tpa=tissue plasminogen activator Slide adapted from acc.org Source: Biondi-Zoccai GGL et al. JACC 2003;41:1071-1077

Take Ac7on! 1. Know your numbers ü Hemoglobin A1C (HgbA1C; goal <7%) ü FasXng Lipid Panel (LDL<100, HDL>50, Triglycerides<150) ü Blood pressure (<130/80) ü Weight and Body Mass Index (goal BMI<25) Know your past (learn your Family History) 11

Take Ac7on! 2. Write it down ü Take inventory (Keep a food log) ü Note triggers for eaxng are you hungry, stressed, bored? Why am I doing this? 12

Take Ac7on! 3. Get moving ü Aim to reduce body weight by 7-10% in the first year ü Do at least 30 minutes of moderate intensity exercise at least 5 Xmes a week ü Make a schedule and keep your gym clothes and shoes in your car so you re ready to go. 13

Take Ac7on! 4. Mind your mouth ü Keep it natural Ø Avoid canned foods, deli meats, red meats, cheeses, processed and packaged foods Ø Reduce intake of saturated and trans fats Ø Aim for no more than 2,400 mg/day of sodium Ø More fruits, vegetables, unsalted nuts, fish ü Make more meals at home ü Daily intake of alcohol should be no more than 1 drink for adult women 14

Take Ac7on! 5. Take your medicaxons as prescribed And keep up with doctor s visits Ask your doctor if you would benefit from a staen (cholesterol medicine) or aspirin 15

ASCVD Risk Calculator EsXmates your risk of having a heart a\ack or stroke in the next 10 years or your lifexme risk h\ps://tools.acc.org/ascvd- Risk- EsXmator/ Do not use this calculator if you have had a heart a\ack or stroke in the past Do not use this calculator if your LDL level is greater than 190 16

EXAMPLE 1: 45 year old woman no risk factors 17

EXAMPLE 2: 45 year old woman with diabetes and no other risk factors 18

Primary Preven7on PrevenXng disease BEFORE it happens ADA/AHA/ACCF recommend low dose aspirin (75-162 mg/day) AKA baby aspirin in adults with DM and no prior vascular history who have a 10- yr CVD risk >10% and who are not at increased risk for bleeding. Increased risk: females >60 years old and males >50 years old with at least 1 more risk factor* * Includes those with family history of premature CVD, hypertension, smoking, dyslipidemia, or albuminuria Pignone M et al. Circula(on 2010;121:2694-2701

Coronary artery calcium (CAC) CAC scan or Heart scan Does not require intravenous contrast Simple CT scan of the heart arteries Looks for presence of calcium Calcium is a marker of atherosclerosis or plaque in the arteries Can improve adherence to medication and lifestyle changes 20

Take Ac7on! 6. Please stop smoking Helpful resources: Your primary care doctor www.smokefree.gov www.cdc.gov/tobacco www.lung.org/stop- smoking 21

Quick Xps Habits are key This is a lifestyle change Knowledge is power Get your family and friends involved Don t be afraid to ask for help. 22

Resources Centers for Disease Control (CDC) American Diabetes AssociaXon (ADA) American Heart AssociaXon (AHA) Goredforwomen.org Cardiosmart.org staxndecisionaid.mayoclinic.org 23

Thank you for your attention! 24